These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11932480)

  • 1. Treatment of acute hepatitis C with interferon alfa-2b.
    Patel R; Germer JJ
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11932480
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute hepatitis C with interferon alfa-2b.
    Jaeckel E; Cornberg M; Wedemeyer H; Santantonio T; Mayer J; Zankel M; Pastore G; Dietrich M; Trautwein C; Manns MP;
    N Engl J Med; 2001 Nov; 345(20):1452-7. PubMed ID: 11794193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
    Sierra F
    J Hepatol; 2007 Feb; 46(2):349; author reply 349-50. PubMed ID: 17161495
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acute hepatitis C with interferon alfa-2b.
    Seligman HK; Fox RK
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936120
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acute hepatitis C with interferon alfa-2b.
    Tocci G; Visco-Comandini U; Antonucci G
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936121
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy for acute hepatitis C.
    Hoofnagle JH
    N Engl J Med; 2001 Nov; 345(20):1495-7. PubMed ID: 11794202
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b.
    Sharara AI; Aoun E; Koussa S; Inati A; Taher A
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1221. PubMed ID: 16824084
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic hepatitis C].
    Fehér J; Lengyel G
    Orv Hetil; 2004 May; 145(20):1065-7. PubMed ID: 15202329
    [No Abstract]   [Full Text] [Related]  

  • 9. Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.
    Scotto G; Palumbo E; Fazio V; Cibelli DC; Saracino A; Angarano G
    Infection; 2005 Feb; 33(1):30-2. PubMed ID: 15750757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
    Malnick SD; Basevitch A
    Gastroenterology; 2006 Aug; 131(2):683; author reply 683-4. PubMed ID: 16890628
    [No Abstract]   [Full Text] [Related]  

  • 11. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatitis C virus infection].
    Zeuzem S
    Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 14. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute hepatitis C with interferon alfa-2b.
    Muir A; Rockey DC
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936122
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
    Crippin JS; McCashland T; Terrault N; Sheiner P; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):350-5. PubMed ID: 11965579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.